.jpg)
.png)
NLA News
August President's Message Dr. Joseph Saseen takes a look ahead at what is to come for the NLA, including LipidPALOOZA in September!
(JACKSONVILLE, FLA.)—The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election came just prior to the organization’s Annual Scientific Sessions held May 1–4 in Orlando, Fla. Terry A. Jacobson, MD, FNLA... more
The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on Lipid Disorders in Children and Adolescents: Screening. NLA leadership disagrees with this release and communicated twice to USPSTF about the implications of this statement. The... more
During February—which is American Heart Month—the National Lipid Association (NLA) would like to recognize the important work underway by Million Hearts. This national initiative was launched by the Department of Health and Human Services in 2012, with the exciting goal of preventing 1 million... more
The National Lipid Association now has 100 lifetime members, which means $100,000 has been set aside for fellowship training programs in lipidology. The NLA is offering this program only through the end of 2013. How does lifetime membership work? It’s simple: Anyone who has been a member... more
By Carl E. Orringer, MD, FACC; Pamela Bowe Morris, MD, FACC; Donald M. Lloyd-Jones, MD, FACC Guideline-directed patient care recommendations are based upon studies that make observations on groups of subjects who have specific characteristics and exhibit variable degrees of benefit or harm... more
MIAMI, Fla. – (May 16, 2019) – Findings of the first patient statin use survey based on a comprehensive set of patient experiences and behavioral markers were presented today at the National Lipid Association’s (NLA) 2019 Scientific Sessions. The Statin Adverse Treatment... more
The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on... more
Olezarsen met the primary endpoint with a statistically significant reduction in triglyceride levels versus placebo First study to show an absolute reduction in acute pancreatitis in FCS patients, with olezarsen 80 mg monthly dose reducing events by 100 percent... more
In 2014, the Foundation of the National Lipid Association (FNLA), Preventive Cardiovascular Nurses Association (PCNA), and Mended Hearts launched Cholesterol Counts, a program designed to accumulate Internet-based information on how much people know about their cholesterol, how much they care about... more